BioNeutra Global Corporation
BGA.V
TSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -7.98% | -34.88% | 23.33% | 5.49% | -102.08% |
| Total Depreciation and Amortization | 20.58% | -8.15% | -4.88% | -4.61% | 0.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,304.00% | -93.80% | 162.94% | -237.02% | 6.29% |
| Change in Net Operating Assets | 67.12% | -12.45% | -56.89% | 422.23% | 139.12% |
| Cash from Operations | 246.83% | -166.09% | -58.69% | 309.30% | 64.01% |
| Capital Expenditure | 79.22% | -381.25% | -107.62% | 172.66% | 45.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | 13.06% |
| Cash from Investing | 67.53% | -381.25% | -107.62% | 140.23% | 30.59% |
| Total Debt Issued | 1,261.54% | -- | -- | -71.37% | -- |
| Total Debt Repaid | -58.36% | 53.32% | -5.69% | -343.86% | 114.10% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 100.49% | -21.78% | 77.32% | -251.65% |
| Cash from Financing | 809.02% | 88.14% | -221.86% | -358.91% | -8.19% |
| Foreign Exchange rate Adjustments | -260.03% | 177.13% | 74.62% | -545.61% | -24.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 372.62% | 13.35% | -774.79% | 94.03% | 72.68% |
